Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C10orf71 antisense RNA 1 (C10orf71-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the C10orf71 locus in the human genome[3]. It is annotated as a non-protein-coding transcript and is thought to act through RNA-based regulatory functions, likely modulating the expression or processing of the sense C10orf71 gene. There is currently no published evidence of specific biological function, disease association, or role as a therapeutic target for C10orf71-AS1. It is listed in gene databases, but there are no known interacting drugs, disease links, or biomarker status. The molecule is not a receptor, enzyme, transporter, or classical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C10orf71 antisense RNA 1 (C10orf71-AS1).